Autologous white blood cell transfusion: Toward a younger immunity

Human Immunology

Volumn 68, Issue 10, 2007, Pages 805-812

  Charron, Dominique ^a  

^a INSERM   (France)

Author keywords

Adoptive immunotherapy; Autologous transfusion; Immunosenescence; WBC

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BLOOD AUTOTRANSFUSION; CANCER; CRYOPRESERVATION; DENDRITIC CELL; DISEASE COURSE; DISEASE SEVERITY; IMMUNITY; INCIDENCE; INFECTION; LEUKOCYTE; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCYTE; PREVENTION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; T LYMPHOCYTE;

CELL AGING; CRYOPRESERVATION; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKOCYTE TRANSFUSION; LEUKOCYTES; LYMPHOCYTES; NEOPLASMS; TIME; TRANSPLANTATION, AUTOLOGOUS;

EID: 35348949621     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.07.004     Document Type: Review

References (67)

1. Luban N.L. Transfusion safety: Where are we today?. Ann N Y Acad Sci 1054 (2005) 325
2. Lowenthal R.M., Grossman L., Goldman J.M., Storring R.A., Buskard N.A., Park D.S., et al. Granulocyte transfusions in treatment of infections in patients with acute leukemia and aplastic anemia. Lancet 1 (1975) 353
3. Awedan A.A. High intensity regimens with autologous hematopoietic stem cell transplantation as treatment of multiple myeloma. Ann Transplant 7 (2002) 38
4. Porter D.L., and June C.H. T-cell reconstitution and expansion after hematopoietic stem cell transplantation: 'T' it up!. Bone Marrow Transplant 35 (2005) 935
5. Toubert A., Clave E., Talvensaari K., Douay C., and Charron D. New tools in assessing immune reconstitution after hematopoietic stem cell transplantation. Vox Sang 78 Suppl 2 (2000) 29
6. Kolb H.J., Mittermuller J., Clemm C., Holler E., Ledderose G., Brehm G., et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76 (1990) 2462
7. Luznik L., and Fuchs E.J. Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation. Cancer Control 9 (2002) 123
8. Kolb H.J., Schattenberg A., Goldman J.M., Hertenstein B., Jacobsen N., Arcese W., et al., European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 86 (1995) 2041
9. Hromas R., Cornetta K., Srour E., Blanke C., and Broun E.R. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation. Blood 84 (1994) 1689
10. Kishi Y., Kami M., Oki Y., Kazuyama Y., Kawabata M., Miyakoshi S., et al. Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation. Bone Marrow Transplant 26 (2000) 573
11. Riddell S.R., Watanabe K.S., Goodrich J.M., Li C.R., Agha M.E., and Greenberg P.D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257 (1992) 238
12. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., and Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333 (1995) 1038
13. Rooney C.M., Smith C.A., Ng C.Y., Loftin S.K., Sixbey J.W., Gan Y., et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 92 (1998) 1549
14. Foster E., and Rooney C.M. Improving T cell therapy for cancer. Expert Opin Biol Ther 6 (2006) 215
15. Ferrantini M., Capone I., Marincola F.M., Parmiani G., and Belardelli F. International meeting. Immunotherapy of cancer: challenges and needs. Cancer Immunol Immunother 56 (2007) 581
16. Foundation of healthy aging. [Editorial]. Immunity 24 (2006) 489
17. Kiehn T.E. Bacteremia and fungemia in the immunocompromised patient. Eur J Clin Microbiol Infect Dis 8 (1981) 832
18. Heemskerk B., van Vreeswijk T., Veltrop-Duits L.A., Sombroek C.C., Franken K., Verhoosel R.M., et al. Adenovirus-specific CD4+ T cell clones recognizing endogenous antigen inhibit viral replication in vitro through cognate interaction. J Immunol 177 (2006) 8851
19. Wade J.C. Viral infections in patients with hematological malignancies. Hematology Am Soc Hematol Educ Program (2006) 368
20. Huang L., and Koziel M.J. Immunology of hepatitis C virus infection. Curr Opin Gastroenterol 16 (2000) 558
21. Hollenbaugh J.A., and Dutton R.W. IFN-gamma regulates donor CD8 T cell expansion, migration, and leads to apoptosis of cells of a solid tumor. J Immunol 177 (2006) 3004
22. Dunn G.P., Koebel C.M., and Schreiber R.D. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6 (2006) 836
23. Tang Q., and Bluestone J.A. Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 212 (2006) 217
24. Hodes R.J. Aging and the immune system. Curr Opin Immunol 17 (2005) 455
25. Haynes L. The effect of aging on cognate function and development of immune memory. Curr Opin Immunol 17 (2005) 476
26. Weksler M.E., Goodhardt M., and Szabo P. The effect of age on B cell development and humoral immunity. Springer Semin Immunopathol 24 (2002) 35
27. Singh H., and Pongubala J.M. Gene regulatory networks and the determination of lymphoid cell fates. Curr Opin Immunol 18 (2006) 116
28. Morrison S.J., Wandycz A.M., Akashi K., Globerson A., and Weissman I.L. The aging of hematopoietic stem cells. Nat Med 2 (1996) 1011
29. Labrie III J.E., Sah A.P., Allman D.M., Cancro M.P., and Gerstein R.M. Bone marrow microenvironmental changes underlie reduced RAG-mediated recombination and B cell generation in aged mice. J Exp Med 200 (2004) 411
30. Haynes L., and Swain S.L. Why aging T cells fail: Implications for vaccination. Immunity 24 (2006) 663
31. McVoy M.A., and Adler S.P. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis 160 (1989) 1
32. Morgan R., and King D. Influenza vaccination in the elderly. Postgrad Med J 72 (1996) 339
33. Kapasi Z.F., Murali-Krishna K., McRe M.L., and Ahmed R. Defective generation but normal maintenance of memory T cells in old mice. Eur J Immunol 32 (2002) 1567
34. Janssen E.M., Droin N.M., Lemmens E.E., Pinkoski M.J., Bensinger S.J., Ehst B.D., et al. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 (2005) 88
35. Homann D., Teyton L., and Oldstone M.B. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory. Nat Med 7 (2001) 913
36. Deng Y., Jing Y., Campbell E., and Gravenstein S. Age-related impaired type 1 T cell responses to influenza: Reduced activation ex vivo, decreased expansion in CTL culture in vitro, and blunted response to influenza vaccination in vivo in the elderly. J Immunol 172 (2004) 3437
37. Lustgarten J., Dominguez A.L., and Thoman M. Aged mice develop protective antitumor immune responses with appropriate costimulation. J Immunol 173 (2004) 4510
38. Goronzy J.J., and Weyand C.M. T cell development and receptor diversity during aging. Curr Opin Immunol 17 (2005) 468
39. Clave E., Rocha V., Talvensaari K., Busson M., Douay C., Appert M.L., et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 105 (2005) 2608
40. Storek J., Joseph A., Espino G., Dawson M.A., Douek D.C., Sullivan K.M., et al. Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation. Blood 98 (2001) 3505
41. Vezys V., Masopust D., Kemball C.C., Barber D.L., O'Mara L.A., Larsen C.P., et al. Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J Exp Med 203 (2006) 2263
42. Sadighi Akha A.A., and Miller R.A. Signal transduction in the aging immune system. Curr Opin Immunol 17 (2005) 486
43. Grolleau-Julius A., Garg M.R., Mo R., Stoolman L.L., and Yung R.L. Effect of aging on bone marrow-derived murine CD11c+CD4-CD8alpha-dendritic cell function. J Gerontol A Biol Sci Med Sci 61 (2006) 1039
44. Fulop T., Larbi A., Douziech N., Fortin C., Guerard K.P., Lesur O., et al. Signal transduction and functional changes in neutrophils with aging. Aging Cell 3 (2004) 217
45. Boehmer E.D., Goral J., Faunce D.E., and Kovacs E.J. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J Leukoc Biol 75 (2004) 342
46. Gomez C.R., Boehmer E.D., and Kovacs E.J. The aging innate immune system. Curr Opin Immunol 17 (2005) 457
47. Broxmeyer H.E. Cord blood: Biology, immunology, banking and clinical transplantation (2004), AABB Press, Bethesda, MD
48. Zheng B., Han S., Takahashi Y., and Kelsoe G. Immunosenescence and germinal center reaction. Immunol Rev 160 (1997) 63
49. Eaton S.M., Burns E.M., Kusser K., Randall T.D., and Haynes L. Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses. J Exp Med 200 (2004) 1613
50. Vu T., Farish S., Jenkins M., and Kelly H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20 (2002) 1831
51. Cook J.M., Gualde N., Hessel L., Mounier M., Michel J.P., Denis F., et al. Alterations in the human immune response to the hepatitis B vaccine among the elderly. Cell Immunol 109 (1987) 89
52. Hainz U., Jenewein B., Asch E., Pfeiffer K.P., Berger P., and Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 23 (2005) 3232
53. Musher D.M., Chapman A.J., Goree A., Jonsson S., Briles D., and Baughn R.E. Natural and vaccine-related immunity to Streptococcus pneumonie. J Infect Dis 154 (1986) 245
54. Cho H.I., Hong Y.S., Lee M.A., Kim E.K., Yoon S.H., Kim C.C., et al. Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas. Int J Hematol 83 (2006) 66
55. Schirrmacher V. T cell-mediated immunotherapy of metastases: State of the art in 2005. Expert Opin Biol Ther 5 (2005) 1051
56. Poehlein C.H., Ruttinger D., Ma J., Hu H.M., Urba W.J., and Fox B.A. Immunotherapy for melanoma: The good, the bad, and the future. Curr Oncol Rep 7 (2005) 383
57. Kalinski P., Mailliard R.B., Giermasz A., Zeh H.J., Basse P., Bartlett D.L., et al. Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opin Biol Ther 5 (2005) 1303
58. Morgan R.A., Dudley M.E., Wunderlich J.R., Hughes M.S., Yang J.C., Sherry R.M., et al. Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314 (2006) 126
59. Mackensen A., Meidenbauer N., Vogl S., Laumer M., Berger J., and Andreesen R. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma. J Clin Oncol 24 (2006) 5060
60. Cheadle E.J., Gilham D.E., Thistlethwaite F.C., Radford J.A., and Hawkins R.E. Killing of non-Hodgkin lymphoma cells by autologous CD19 engineered T cells. Br J Hematol 129 (2005) 322
61. Fishman M., and Seigne J. Immunotherapy of metastatic renal cell cancer. Cancer Control 9 (2002) 293
62. Takayama T., Sekine T., Makuuchi M., Yamasaki S., Kosuge T., Yamamoto J., et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: A randomised trial. Lancet 356 (2000) 802
63. Jiang J., Xu N., Wu C., Deng H., Lu M., Li M., et al. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells. Anticancer Res 26 (2006) 2237
64. Peethambaram P.P., and Long H.J. Second-line and subsequent therapy for ovarian carcinoma. Curr Oncol Rep 4 (2002) 159
65. Plautz G.E., Miller D.W., Barnett G.H., Stevens G.H., Maffett S., Kim J., et al. T cell AI of newly diagnosed gliomas. Clin Cancer Res 6 (2000) 2209
66. To W.C., Wood B.G., Krauss J.C., Strome M., Esclamado R.M., Lavertu P., et al. Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: A phase 1 study. Arch Otolaryngol Head Neck Surg 126 (2000) 1225
67. Mizutani Y., Yoshida O., and Miki T. Adriamycin-mediated potentiation of cytotoxicity against freshly isolated bladder cancer cells by autologous non-activated peripheral blood lymphocytes and tumor infiltrating lymphocytes. Urol 162 (1999) 2170